Literature DB >> 11442529

Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma.

T Uenishi1, K Hirohashi, S Kubo, T Yamamoto, O Yamazaki, H Kinoshita.   

Abstract

BACKGROUND: The prognosis for patients with intrahepatic cholangiocarcinoma differs according to macroscopic type. The identification of clinical and pathological features that predict outcome in patients with mass-forming intrahepatic cholangiocarcinoma is required in order to determine optimal surgical strategies for patients with this type of tumour.
METHODS: The details of 35 patients with resected mass-forming intrahepatic cholangiocarcinomas were analysed retrospectively. Univariate analysis of potential prognostic factors was performed.
RESULTS: The cumulative survival rate at 1, 3 and 5 years after operation was 58, 33 and 33 per cent respectively. Patients with stage II tumours had a better outcome than those with advanced stage tumours. By univariate analysis, lymphatic invasion, lymph node metastasis, intrahepatic satellite lesions and microscopic resection margin involvement were found to be highly significant variables and were identified as possible risk factors for a poor outcome after operation.
CONCLUSION: When frozen-section examination of lymph nodes reveals negative nodal metastasis, extensive anatomical hepatic resection is indicated for mass-forming intrahepatic cholangiocarcinomas. Intraoperative frozen-section examination of the resection margin to confirm the absence of cancer cells is recommended.

Entities:  

Mesh:

Year:  2001        PMID: 11442529     DOI: 10.1046/j.0007-1323.2001.01784.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.

Authors:  Siobhan C McKay; Kristian Unger; Stephanos Pericleous; Gordon Stamp; Gerry Thomas; Robert R Hutchins; Duncan R C Spalding
Journal:  HPB (Oxford)       Date:  2011-03-10       Impact factor: 3.647

2.  Liver transplantation is not indicated for cholangiocarcinoma.

Authors:  C Wright Pinson; Derek E Moore
Journal:  HPB (Oxford)       Date:  2003       Impact factor: 3.647

3.  Pure laparoscopic right hepatectomy by anterior approach with hanging maneuver for large intrahepatic cholangiocarcinoma.

Authors:  Masahiro Takahashi; Go Wakabayashi; Hiroyuki Nitta; Daiki Takeda; Yasushi Hasegawa; Takeshi Takahara; Naoko Ito
Journal:  Surg Endosc       Date:  2013-10-30       Impact factor: 4.584

4.  Prediction of the postoperative prognosis of intrahepatic cholangiocarcinoma (ICC): importance of preoperatively- determined anatomic invasion level and number of tumors.

Authors:  Shigeru Marubashi; Kunihito Gotoh; Hidenori Takahashi; Hiroaki Ohigashi; Masahiko Yano; Osamu Ishikawa; Masato Sakon
Journal:  Dig Dis Sci       Date:  2014-01       Impact factor: 3.199

5.  Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma.

Authors:  Dario Ribero; Gennaro Nuzzo; Marco Amisano; Mariano Tomatis; Alfredo Guglielmi; Stefano Maria Giulini; Luca Aldrighetti; Fulvio Calise; Giorgio Enrico Gerunda; Antonio Daniele Pinna; Lorenzo Capussotti
Journal:  HPB (Oxford)       Date:  2011-02-09       Impact factor: 3.647

6.  A case of intrahepatic cholangiocarcinoma detected after successful interferon therapy for chronic hepatitis C.

Authors:  Hiroji Shinkawa; Seikan Hai; Hiromu Tanaka; Shigekazu Takemura; Kazuki Ohba; Takahiro Uenishi; Shintaro Kodai; Yorihisa Urata; Kazuhisa Kaneda; Masayuki Sakae; Kenichi Wakasa; Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2009-12-03

7.  CT evaluation of paraaortic lymph node metastasis in patients with biliary cancer.

Authors:  Takehiro Noji; Satoshi Kondo; Satoshi Hirano; Eiichi Tanaka; Yoshiyasu Ambo; Yo Kawarada; Toshiaki Morikawa
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

8.  Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery.

Authors:  Shiro Miwa; Shinichi Miyagawa; Akira Kobayashi; Yasuhiko Akahane; Takenari Nakata; Motohiro Mihara; Kei Kusama; Junpei Soeda; Shinichiro Ogawa
Journal:  J Gastroenterol       Date:  2006-09       Impact factor: 7.527

Review 9.  Hepatitis B virus and hepatitis C virus play different prognostic roles in intrahepatic cholangiocarcinoma: A meta-analysis.

Authors:  Zheng Wang; Yuan-Yuan Sheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

10.  Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer.

Authors:  T Uenishi; S Kubo; K Hirohashi; H Tanaka; T Shuto; T Yamamoto; S Nishiguchi
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.